BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4130922)

  • 1. [Side-effects in patients treated with dextran].
    Kowal-Gierczak B; Janukowicz-Lorenz H
    Wiad Lek; 1974 Feb; 27(4):341-5. PubMed ID: 4130922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravascular disseminated coagulation syndrome during treatment with dextran 40].
    Wlodarczyk J; Kotschy M; Janukowiez-Lorenz H; Kurzawska M; Prastowski W; Rychlik W
    Pol Tyg Lek; 1975 Feb; 30(7):297-9. PubMed ID: 1167691
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathogenesis of hemostasis disorders due to infusions].
    Perlick E
    Z Gesamte Inn Med; 1970 Aug; 25(15):666-71. PubMed ID: 5527529
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications of 32% dextran-70 in 10% dextrose. A case report.
    Schinco MA; Hughes D; Santora TA
    J Reprod Med; 1996 Jun; 41(6):455-8. PubMed ID: 8799927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anaphylactoid complications related to the use of 40,000- molecular weight dextran].
    Laxenaire MC; Jacob F; Noel P
    Ann Anesthesiol Fr; 1976; 17(2):101-4. PubMed ID: 62526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactic shock, acute renal failure, and disseminated intravascular coagulation. Suspected complications of zomepirac.
    Smith VT
    JAMA; 1982 Feb; 247(8):1172-3. PubMed ID: 7057609
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal toxicity of low molecular weight dextran: a review of the literature.
    Figueroa JE; Burgos-Calderon R
    J La State Med Soc; 1974 Dec; 126(12):425-7. PubMed ID: 4436605
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complications due to injection of high-molecular-weight dextran during the study of the survival in vitro of labelled granulocytes].
    Dresch C; Hurez D; Basch A; Najean Y
    Nouv Rev Fr Hematol; 1970; 10(2):277-84. PubMed ID: 4246280
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of shock with dextrans and gelatins. Effects and side effects.
    Lundsgaard-Hansen P
    Vox Sang; 1969 Sep; 17(3):161-93. PubMed ID: 4187464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case of acute kidney failure induced low-molecular weight dextran effectively treated by plasma exchange].
    Matsushima H; Yonemura K; Nakamura T; Takahashi M; Iketani N
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):294-5. PubMed ID: 7525804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental kidney damage produced by the combined use of low molecular weight dextran and antibiotics].
    Ueda T
    Nihon Jinzo Gakkai Shi; 1974 Jun; 16(6):629-56. PubMed ID: 4478698
    [No Abstract]   [Full Text] [Related]  

  • 12. [Volume substitution with dextran].
    Gruber UF
    Krankenpfl J; 1981 Dec; 19(12):19-21. PubMed ID: 6174774
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute renal failure caused by dextran of low molecular weight].
    Alvarez Grande H; Oliva Aldámiz H; López de Novales E; Barrientos Guzmán A; Hernando Avendaño L
    Rev Clin Esp; 1970 Jan; 116(2):169-72. PubMed ID: 5453847
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dextran-intolerance (author's transl)].
    Misgeld V; Mende C
    Med Klin; 1974 Sep; 69(36):1452-5. PubMed ID: 4140461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disseminated intravascular coagulation during Rheomacrodex therapy].
    Hajnal F; Kiss Z
    Orv Hetil; 1983 Mar; 124(11):641-2. PubMed ID: 6189045
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heart arrest and shock caused by low molecular dextran (Rheomacrodex)].
    Schobinger RA
    Helv Chir Acta; 1970 Apr; 37(1):9-11. PubMed ID: 4107167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Morphology of renal structures in the dog after prolonged administration of Plasmacair].
    Boutet G; Labie C; Besson F
    Agressologie; 1989; 30(9-10):525-8. PubMed ID: 2483033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute oliguric renal failure associated with low-molecular-weight dextran.
    Burgos-Calderón R; Figueroa JE
    Bol Asoc Med P R; 1972 Jan; 64(1):1-4. PubMed ID: 4501148
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of intravascular coagulation].
    Sutor AH
    Monatsschr Kinderheilkd (1902); 1975 Jul; 123(7):565-8. PubMed ID: 1173934
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fatal anuria after perfusion of low molecular weight dextran].
    Auquier L; Paolaggi JB; Rouques C; Dastugue B
    Therapie; 1968; 23(4):751-4. PubMed ID: 5744586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.